There are 2 categories of challenges facing oncology practices as they transition to value-based payment models, said Aaron Lyss, director of value-based care for Tennessee Oncology.
Transcript (slightly modified)
What have been the biggest challenges practices run into while shifting to value-based payment models?
I’ll give you 2 categories of challenges. There are really significant blocking and tackling challenges involved in managing value-based payment programs. For example, accurately tracking the patient episodes you have included in this program—that’s not a trivial undertaking. It actually requires a lot of sophisticated work on the community oncology side in order to accurately track initiation and termination of the episodes that are involved in their models, as well as the clinical data and quality reporting. Those reporting burdens in the way that these models, especially the Medicare models that have been constructed up to this point, really are incredibly burdensome to practices and make it hard for them to focus on what they need to do in order to meet the objectives of enhancing care for patients as well as minimizing unnecessary healthcare costs. So, the resources that practices have wrapped up in clinical data and quality measure reporting, burdens are really a distraction from the overarching objective that they need to accomplish in mitigating unnecessary healthcare costs and enhancing the patient experience.